Knowledge Library Prototype
Pediatrics Intelligence
Prototype collection covering pediatric therapeutics, vaccines, neonatal and adolescent care, rare diseases, infectious disease, medication safety, FDA pediatric updates, clinical trials, and AJPPS research.
Featured AJPPS Research
Placeholder for AJPPS pediatric pharmacy, therapeutics, vaccines, and child health research.
Latest Pediatrics Intelligence
Reserved for approved RSS/API content relevant to pediatric care and pharmaceutical sciences.
FDA & Regulatory Updates
- BsUFA IV: Fiscal Years 2028-2032
by FDA on 07/16/2026 at 5:00 pmOn September 30, 2022, the President signed into law the FDA User Fee Reauthorization Act of 2022.
- MantroForce - 729021 - 06/17/2026by FDA on 07/16/2026 at 4:35 pm
Unapproved New Drugs/Misbranded
- CDER Small Business & Industry Assistance (SBIA)by FDA on 07/16/2026 at 4:34 pm
A Comprehensive Resource for Information on Human Drug Development in Regulation
- Wholesale Peptide - 729447 - 06/17/2026by FDA on 07/16/2026 at 4:22 pm
Unapproved New Drugs/Misbranded
- Texinkart Inc. - 729046 - 06/17/2026by FDA on 07/16/2026 at 4:20 pm
Unapproved New Drugs/Misbranded
Clinical Trials Watch
Future ClinicalTrials.gov integration for pediatric diseases, vaccines, rare disorders, and pediatric therapeutics.
Clinical Practice & Therapeutics
Future summaries should support pediatric dosing, safety, counseling, immunization, and medication-use decisions.
Related Collections
- Infectious Disease & Antimicrobial Stewardship
- FDA Approvals & Medication Safety
- Pharmacogenomics Intelligence